SCHEMBL21971001

SCHEMBL21971001

COc1ccc(N(C)C)c(C2N(C)c3ccccc3N2C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.51
▸ PDGFRB P09619 1/20 0.43
▸ SLC6A2 P23975 2/20 0.37
▸ SLC6A4 P31645 2/20 0.37
▸ SLC6A3 Q01959 2/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ HRH1 P35367 1/20 0.37
▸ SNCA P37840 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2A6 P11509 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21971005 0.88 LMNA (0.51) LMNAPDGFRBSLC6A2SLC6A4SLC6A3
SCHEMBL21971003 0.80 PDGFRB (0.58) LMNAPDGFRBSNCAALDH1A1KDM4E
SCHEMBL21972258 0.79 LMNA (0.46) LMNAPDGFRBHTR2AHTR2CHRH1
SCHEMBL20508364 0.77 PDGFRB (0.53) LMNAPDGFRBSLC6A2SLC6A4HTR2A
SCHEMBL21971007 0.75 LMNA (0.49) LMNAPDGFRBSLC6A2SLC6A4SLC6A3
SCHEMBL21972255 0.74 LMNA (0.42) LMNAPDGFRBHTR2AHTR2CHRH1
SCHEMBL21972251 0.74 LMNA (0.49) LMNAPDGFRBCYP1A2ALDH1A1KDM4E
SCHEMBL21971009 0.73 LMNA (0.63) LMNAPDGFRBSNCAALDH1A1KDM4E
SCHEMBL21970632 0.71 PDGFRB (0.42) LMNAPDGFRBALDH1A1KDM4EMAPT
SCHEMBL21891263 0.71 PDGFRB (0.58) LMNAPDGFRBALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046655-B2 Compound and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME CBR3, NR2E3, NR5A2 LMNA 4733/4885PDGFRB 2517/4885SLC6A2 3096/4885
US-11046655-B2 Compound and method for producing same CBR3, NR5A1, NR2E3 LMNA 4570/4885PDGFRB 2499/4885SLC6A2 2900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback